Icahn calls Mylan deal too pricey
97449
Investor Carl Icahn on Thursday detailed his objections to Mylan Laboratories Inc.&#39;s proposed $4 billion acquisition of King Pharmaceuticals Inc.
610073
Billionaire investor Carl Icahn said  on Thursday he made an offer to buy certain Westchester  properties held by Reckson Associates Realty Corp.  as  part of its pending merger with SL Green Realty Corp .
84238
Mylan Laboratories Inc. MYL.N on  Friday said its board of directors remains committed to the  purchase of King Pharmaceuticals Inc. KG.N, despite news that  billionaire investor Carl Icahn won regulatory approval to buy  up to 11.9 percent of Mylan's shares.
755767
Mylan Laboratories Inc.'s MYL.N board  on Monday rebuffed financier Carl Icahn's bid to buy the  company, and said it remains committed to its $3.37 billion  purchase of brand-name drug-maker King Pharmaceuticals Inc.  KG.N.
723851
Generic drug maker Mylan Laboratories Inc.  said on Friday it expects to raise $993.6 million, following a pricing of its public offerings of notes and shares.
754264
PHILADELPHIA, Aug 19  - Shares of Mylan Laboratories Inc. (MYL.N: Quote, Profile, Research) surged more than 10 percent on Thursday after billionaire investor Carl Icahn got federal regulatory approval to buy up 11.9 percent of ...
603432
PITTSBURGH The chief executive of Mylan Laboratories says a move by Wall Street financier Carl Icahn (EYE&#39;-kahn) to halt Mylan&#39;s acquisition of King Pharmaceuticals is wrongheaded.
140980
Billionaire investor Carl Icahn's American Real Estate Partners LP  raised its takeover offer for Lear Corp.  to about $3 billion after shareholders balked at a previous buyout proposal.
543076
Financier Carl Icahn said Monday King Pharmaceutical Inc.&#39;s possible need to restate earnings reinforces his belief that an acquisition of King by Mylan Laboratories Inc.
114843
-- Mylan Laboratories Inc. on Wednesday said it was unlikely to complete its &#36;3.37 billion acquisition of King Pharmaceuticals Inc. at the current price because of King's need to restate earnings.
107025
Mylan Laboratories Inc. continued to insist Monday that its $4 billion acquisition of King Pharmaceuticals Inc. was in the company&#39;s best interest, following a meeting last week with Carl Icahn, who opposes the deal.
404301
Mylan Laboratories Inc., the largest US maker of generic drugs, cautioned investors Friday that Thursday&#39;s jump in share price was likely driven by investor Carl Icahn&#39;s clearance to buy a large amount of company stock and fails to reflect &quot;negative ...
384162
Reckson Associates Realty Corp.  on Tuesday said its board voted against a $4.3 billon takeover offer from billionaire financier Carl Icahn, saying the bid wasn't better than an offer from rival office landlord SL Green Realty Corp.
210669
Mylan Laboratories Inc. MYL.N on  Wednesday said investor Carl Icahn's opposition to Mylan's  proposed purchase of King Pharmaceuticals Inc. KG.N does not  affect Mylan's commitment to complete the transaction.
748008
Icahn is involved in the Mylan-King Pharmaceuticals deal for his benefit only.
362567
WASHINGTON An investment firm has told Mylan Laboratories that a proposed acquisition of King Pharmaceuticals is not in the best interests of investors.
247690
Carl Icahn has launched another of his multibillion-dollar shock-and-awe raids for a company - this time on the nation&#39;s biggest generic drug maker, Mylan.